AGENUS INC Earnings Per Share (Basic)
AGENUS INC (AGEN) reported Earnings Per Share (Basic) of -$0.01 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-07
- AGENUS INC earnings per share, basic for the quarter ending 2026-06-30 was -$0.01.
- AGENUS INC earnings per share, basic for the quarter ending 2026-03-31 was $1.03.
- AGENUS INC earnings per share, basic for the quarter ending 2025-12-31 was -$0.31.
- AGENUS INC earnings per share, basic for the quarter ending 2025-09-30 was $2.00.
- AGENUS INC earnings per share, basic for fiscal 2025 was $0.00.
- AGENUS INC earnings per share, basic for fiscal 2024 was -$10.59.
- AGENUS INC earnings per share, basic for fiscal 2023 was -$13.75.
- AGENUS INC earnings per share, basic for fiscal 2022 was -$15.64.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.01 10-Q · filed 2026-08-07 | $0.97 10-Q · filed 2026-08-07 | $0.74 derived: net income ÷ weighted average shares · filed 2026-08-07 | $2.52 derived: net income ÷ weighted average shares · filed 2026-08-07 | ||||
| 2026-03-31 | $1.03 10-Q · filed 2026-05-11 | $0.79 derived: net income ÷ weighted average shares · filed 2026-05-11 | $2.66 derived: net income ÷ weighted average shares · filed 2026-05-11 | $1.95 derived: net income ÷ weighted average shares · filed 2026-08-07 | ||||
| 2025-12-31 | -$0.31 derived: net income ÷ weighted average shares · filed 2026-03-16 | $1.61 derived: net income ÷ weighted average shares · filed 2026-03-16 | $0.80 derived: net income ÷ weighted average shares · filed 2026-08-07 | $0.00 10-K · filed 2026-03-16 | ||||
| 2025-09-30 | $2.00 10-Q · filed 2025-11-10 | $1.19 derived: net income ÷ weighted average shares · filed 2026-08-07 | $0.37 10-Q · filed 2025-11-10 | -$1.32 derived: net income ÷ weighted average shares · filed 2026-08-07 | ||||
| 2025-06-30 | -$1.00 10-Q · filed 2026-08-07 | -$2.03 10-Q · filed 2026-08-07 | -$3.94 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$6.83 derived: net income ÷ weighted average shares · filed 2026-08-07 | ||||
| 2025-03-31 | -$1.03 10-Q · filed 2026-05-11 | -$3.01 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$5.99 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$8.48 derived: net income ÷ weighted average shares · filed 2026-05-11 | ||||
| 2024-12-31 | -$2.00 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$5.05 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$7.58 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$10.59 10-K · filed 2026-03-16 | ||||
| 2024-09-30 | -$3.08 10-Q · filed 2025-11-10 | -$5.61 derived: net income ÷ weighted average shares · filed 2025-11-10 | -$8.65 10-Q · filed 2025-11-10 | -$11.09 derived: net income ÷ weighted average shares · filed 2026-03-16 | ||||
| 2024-06-30 | -$2.52 10-Q · filed 2025-08-11 | -$5.56 10-Q · filed 2025-08-11 | -$7.99 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$11.25 derived: net income ÷ weighted average shares · filed 2026-03-16 | ||||
| 2024-03-31 | -$3.04 10-Q · filed 2025-05-12 | -$5.47 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$8.75 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$12.60 derived: net income ÷ weighted average shares · filed 2026-03-16 | ||||
| 2023-12-31 | -$2.41 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$5.70 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$9.57 derived: net income ÷ weighted average shares · filed 2026-03-16 | -$13.75 10-K · filed 2026-03-16 | -$0.69 10-K · filed 2024-03-14 | |||
| 2023-09-30 | -$3.29 10-Q · filed 2024-11-12 | -$0.16 10-Q · filed 2023-11-09 | -$7.20 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$11.43 10-Q · filed 2024-11-12 | -$0.57 10-Q · filed 2023-11-09 | -$10.04 derived: net income ÷ weighted average shares · filed 2025-03-17 | ||
| 2023-06-30 | -$3.93 10-Q · filed 2024-08-08 | -$0.20 10-Q · filed 2023-08-08 | -$8.22 10-Q · filed 2024-08-08 | -$0.41 10-Q · filed 2023-08-08 | -$7.03 derived: net income ÷ weighted average shares · filed 2025-03-17 | -$11.78 derived: net income ÷ weighted average shares · filed 2025-03-17 | ||
| 2023-03-31 | -$4.31 10-Q · filed 2024-05-07 | -$0.22 10-Q · filed 2023-05-09 | -$3.91 derived: net income ÷ weighted average shares · filed 2025-03-17 | -$8.11 derived: net income ÷ weighted average shares · filed 2025-03-17 | -$13.36 derived: net income ÷ weighted average shares · filed 2025-03-17 | |||
| 2022-12-31 | -$1.28 derived: net income ÷ weighted average shares · filed 2025-03-17 | -$4.49 derived: net income ÷ weighted average shares · filed 2025-03-17 | -$9.19 derived: net income ÷ weighted average shares · filed 2025-03-17 | -$15.64 10-K · filed 2025-03-17 | -$0.78 10-K · filed 2023-03-16 | |||
| 2022-09-30 | -$0.19 10-Q · filed 2023-11-09 | -$357.38 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$0.54 10-Q · filed 2023-11-09 | -$796.05 derived: net income ÷ weighted average shares · filed 2024-03-14 | ||||
| 2022-06-30 | -$0.17 10-Q · filed 2023-08-08 | -$0.35 10-Q · filed 2023-08-08 | -$607.69 derived: net income ÷ weighted average shares · filed 2024-03-14 | $70.35 derived: net income ÷ weighted average shares · filed 2024-03-14 | ||||
| 2022-03-31 | -$0.19 10-Q · filed 2023-05-09 | -$442.53 derived: net income ÷ weighted average shares · filed 2024-03-14 | $258.10 derived: net income ÷ weighted average shares · filed 2024-03-14 | -$77.21 derived: net income ÷ weighted average shares · filed 2024-03-14 | ||||
| 2021-12-31 | -$255.47 derived: net income ÷ weighted average shares · filed 2024-03-14 | $459.04 derived: net income ÷ weighted average shares · filed 2024-03-14 | $124.17 derived: net income ÷ weighted average shares · filed 2024-03-14 | -$0.11 10-K · filed 2024-03-14 | ||||
| 2021-09-30 | $0.76 10-Q · filed 2022-11-08 | $415.24 derived: net income ÷ weighted average shares · filed 2022-11-08 | $0.19 10-Q · filed 2022-11-08 | |||||
| 2021-06-30 | -$0.37 10-Q · filed 2022-08-09 | -$0.65 10-Q · filed 2022-08-09 | ||||||
| 2020-12-31 | -$195.16 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$473.14 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$1.05 10-K · filed 2023-03-16 | |||||
| 2020-09-30 | -$0.28 10-Q · filed 2021-11-09 | -$0.87 10-Q · filed 2021-11-09 | ||||||
| 2020-03-31 | -$0.31 10-Q · filed 2020-05-11 | |||||||
| 2019-12-31 | -$0.22 10-K · filed 2021-03-16 | |||||||
| 2019-09-30 | -$0.33 10-K · filed 2021-03-16 | |||||||
| 2019-06-30 | -$0.38 10-K · filed 2021-03-16 | |||||||
| 2019-03-31 | $0.14 10-K · filed 2021-03-16 | |||||||
| 2018-03-31 | -$0.53 10-Q · filed 2019-05-10 | |||||||
| 2015-06-30 | -$0.53 10-Q · filed 2015-08-03 | -$0.83 10-Q · filed 2015-08-03 | ||||||
| 2015-03-31 | -$0.28 10-Q · filed 2015-05-01 | |||||||
| 2014-09-30 | -$0.13 10-Q · filed 2014-10-31 | -$0.28 10-Q · filed 2014-10-31 | ||||||
| 2014-06-30 | -$0.13 10-Q · filed 2015-08-03 | -$0.12 10-Q · filed 2014-08-01 | -$0.15 10-Q · filed 2015-08-03 | |||||
| 2014-03-31 | -$0.01 10-Q · filed 2015-05-01 | |||||||
| 2013-12-31 | -$0.16 10-K · filed 2014-03-07 | |||||||
| 2013-09-30 | -$0.24 10-Q · filed 2014-10-31 | -$0.99 10-Q · filed 2014-10-31 | ||||||
| 2013-06-30 | -$0.40 10-Q · filed 2014-08-01 | -$0.76 10-Q · filed 2014-08-01 | ||||||
| 2013-03-31 | -$0.35 10-Q · filed 2014-05-09 | |||||||
| 2012-12-31 | -$0.23 10-K · filed 2014-03-07 | |||||||
| 2012-09-30 | -$0.24 10-K · filed 2014-03-07 | -$0.28 10-Q · filed 2013-11-08 | ||||||
| 2012-06-30 | -$0.31 10-K · filed 2014-03-07 | -$0.02 10-Q · filed 2013-08-09 | ||||||
| 2012-03-31 | $0.29 10-K · filed 2014-03-07 | |||||||
| 2011-03-31 | -$0.33 10-Q · filed 2012-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |